Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease. [Source]
Publication Date:Origin: nytimes.com
Category: your-feed-science
Topics: Alzheimer’s, disease, moderate, people, decline, cognitive, reduce, significantly, Sciences, Cassava, Results, Disappointing, After, Halted, Controversial, Trial
Source: https://www.nytimes.com/2024/11/25/health/cassava-alzheimers-simuflam.html